Progesterone Receptor Negative Terminated Phase 1 Trials for Vismodegib (DB08828)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01071564RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryTreatment